亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Personalized Protease fingerprinting for early cancer diagnosis

詳細技術說明: UCSD researchers have developed a personalized protease fingerprinting assay which can be useful for improved imaging during surgery and post-surgical assessment of the tumor tissue. The ex vivo assay is based on cleavage of dual fluorescently labeled substrates; the tumor extract’s enzymes cleaves the fluorescent probe, resulting in a personalized profile of the proteases active in that specific tumor. As a proof of concept, the inventors have synthesized the first generation of MMP cleavable probes which have been tested on various (frozen) human tumor samples (breast, head and neck tumors). The resulting protease expression profiles, should make it possible to select the specific probe(s) which can be used for intra-operative imaging and tumor boundary determination. Synthesis of probes for other cancer associated MMPs and non-MMP proteases is underway. The investigators hope to conduct a clinical trial to exploring the correlation of protease activity with several clinically relevant parameters.Sample Data(change in fluoresence/min)Key: 4T1 and 8119 represent mouse breast cancer graftsSCCA2, SCCA5 and SCCA7 represent human head and neck squamous cell carcinomas

*Abstract: Matrix metalloproteinases (MMPs) as well as other proteases play a crucial role in cancer invasion and metastasis. Increase in MMP levels correlate with higher stage, increased cancer grade and higher activity when overexpressed in malignant tumors and is associated with poorer patient prognosis. The expression of proteases in clinical tumors has been studied through measurement of mRNA levels and immunoassays. These techniques monitor the sum of all forms of the protease, much of which is either inactive proenzyme or inactive complexes that have endogenous inhibitor proteins (e.g. TIMPs). Recent methods for detection such as “in situ zymography” is slow and qualitative. The ability to accurately measure and/or monitor the active enzyme in a patient’s tumor could provide improved intra-operative imaging of tumor margins by utilizing a fluorescent probe which is specific for the tumor’s protease(s). Obtaining the expression profile of tissue excised during surgery could aid with the assessment of post-surgical options.

*Principal Investigation: Name: Quyen Nguyen
Department:

Name: Roger Tsien
Department:

Name: Michael Whitney
Department:

其他

Intellectual Property Info

A provisional patent application has been authorized.

Additional Technologies by these Inventors

Tech ID/UC Case

23644/2013-105-0

Related Cases

2013-105-0, 2013-185-0, 2009-220-0

欲了解更多信息，請點擊這裡